Your browser doesn't support javascript.
loading
Integrin αvß8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy.
Dodagatta-Marri, Eswari; Ma, Hsiao-Yen; Liang, Benjia; Li, John; Meyer, Dominique S; Chen, Szu-Ying; Sun, Kai-Hui; Ren, Xin; Zivak, Bahar; Rosenblum, Michael D; Headley, Mark B; Pinzas, Lauren; Reed, Nilgun I; Del Cid, Joselyn S; Hann, Byron C; Yang, Sharon; Giddabasappa, Anand; Noorbehesht, Kavon; Yang, Bing; Dal Porto, Joseph; Tsukui, Tatsuya; Niessen, Kyle; Atakilit, Amha; Akhurst, Rosemary J; Sheppard, Dean.
Affiliation
  • Dodagatta-Marri E; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Ma HY; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Liang B; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China.
  • Li J; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Meyer DS; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Chen SY; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Sun KH; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Ren X; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Zivak B; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.
  • Rosenblum MD; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.
  • Headley MB; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.
  • Pinzas L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Reed NI; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Del Cid JS; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Hann BC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Yang S; Comparative Medicine, Pfizer Inc., San Diego, CA, USA.
  • Giddabasappa A; Oncology Research Unit, Pfizer Inc., Pearl River, NY, USA.
  • Noorbehesht K; Oncology Research Unit, Pfizer Inc., Pearl River, NY, USA.
  • Yang B; Oncology Research Unit, Pfizer Inc., Pearl River, NY, USA.
  • Dal Porto J; Pfizer Centers for Therapeutic Innovation, San Francisco, CA, USA.
  • Tsukui T; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Niessen K; Pfizer Centers for Therapeutic Innovation, San Francisco, CA, USA.
  • Atakilit A; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Akhurst RJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA. Electronic address: rosemary.akhurst@ucsf.edu.
  • Sheppard D; Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. Electronic address: dean.sheppard@ucsf.edu.
Cell Rep ; 36(1): 109309, 2021 07 06.
Article de En | MEDLINE | ID: mdl-34233193
ABSTRACT
αvß8 integrin, a key activator of transforming growth factor ß (TGF-ß), inhibits anti-tumor immunity. We show that a potent blocking monoclonal antibody against αvß8 (ADWA-11) causes growth suppression or complete regression in syngeneic models of squamous cell carcinoma, mammary cancer, colon cancer, and prostate cancer, especially when combined with other immunomodulators or radiotherapy. αvß8 is expressed at the highest levels in CD4+CD25+ T cells in tumors, and specific deletion of ß8 from T cells is as effective as ADWA-11 in suppressing tumor growth. ADWA-11 increases expression of a suite of genes in tumor-infiltrating CD8+ T cells normally inhibited by TGF-ß and involved in tumor cell killing, including granzyme B and interferon-γ. The in vitro cytotoxic effect of tumor CD8 T cells is inhibited by CD4+CD25+ cells, and this suppressive effect is blocked by ADWA-11. These findings solidify αvß8 integrin as a promising target for cancer immunotherapy.
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Intégrines / Immunité / Immunothérapie / Modèles biologiques / Tumeurs Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Cell Rep Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Intégrines / Immunité / Immunothérapie / Modèles biologiques / Tumeurs Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Cell Rep Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique